Zobrazeno 1 - 10
of 13
pro vyhledávání: '"SDHD Gene Mutation"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 4, Pp n/a-n/a (2024)
Key Clinical Messages The newly published clinical consensus guideline on the management of PGL/PCC is helpful for decision‐making for diagnostics and treatment. Still, the treatment of patients with SDHD gene mutations requires an individual appro
Externí odkaz:
https://doaj.org/article/d228fa403746498ab0416de0a4a28738
Autor:
Franz Sesti, Tiziana Feola, Giulia Puliani, Roberta Centello, Valentina Di Vito, Oreste Bagni, Andrea Lenzi, Andrea M. Isidori, Vito Cantisani, Antongiulio Faggiano, Elisa Giannetta
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundParagangliomas (PGLs) are neuroendocrine neoplasms arising from chromaffin cells of sympathetic or parasympathetic paraganglia. Systemic therapies have been used only in metastatic PGLs. Antiangiogenic agents, such as sunitinib, could be a
Publikováno v:
The Laryngoscope. 129:E67-E71
Objectives The goal of this study was to detect and explore the mechanisms of the succinate dehydrogenase (SDH) complex subunit-related gene mutations in cases of multiple paraganglioma (PGL) in the head and neck. Methods In Beijing Tongren Hospital
Autor:
Alfonso Cossío-Zazueta, Jimena Gabriela Muñoz-Paredes, Yam Ontiveros-Carlos, María Elizabeth Enríquez-Vega, Ernesto Pacheco-Pittaluga, Héctor Bizueto-Rosas
Publikováno v:
Cirugía y Cirujanos (English Edition). 86
Among the U.S. population, the p81L SDHD (11q23) gene mutation is present in 6-36% of patients with sporadic carotid body tumor (CBT), but in familial cases is high as 80%. That is why the P81L mutation is used as a screening method for carotid body
Publikováno v:
Nuklearmedizin. 55:34-40
SummaryAim: Hereditary pheochromocytoma-paraganglioma syndromes are characterized by multiple pheochromocytomas (PCC) and paragangliomas (PGLs), inherited in an autosomal dominant manner. Early detection and removal of tumours may prevent or minimize
Autor:
Thorsten D. Poeppel, Ali Yuece, Hartmut P. H. Neumann, Sandra Rosenbaum, Klaus Mann, Elke Kaminsky, Lars C. Moeller, Klaus A. Metz, Christian Boy
Publikováno v:
Journal of Clinical Oncology. 29:e812-e815
Autor:
Nikolett Lendvai, Ildikó Kuritárné Szabó, Gabriella Bekő, Attila Patócs, Sándor Alföldi, Károly Rácz, János Horányi, Henriett Butz, István Szabó, Mária Tarjányi
Publikováno v:
Orvosi Hetilap. 150:645-649
Hereditary paraganglioma/pheochromocytoma syndrome is an autosomal dominantly inherited disease caused by germline mutation of the genes encoding subunits of the mitochondrial succinate dehydrogenase (SDH) enzyme involved in the mitochondrial respira
Publikováno v:
AACE Clinical Case Reports, Vol 2, Iss 2, Pp e91-e95 (2016)
Objective: To report a case of carotid body paraganglioma occurring in conjunction with a succinate dehydrogenase complex subunit D (SDHD) gene mutation with comorbidities of multiple retroperitoneal paragangliomas and pheochromocytoma. This case emp
Autor:
Michinori Takahashi, Mitsuhide Naruse, Kenji Honkura, Sho Hashimoto, Kazutsugu Iwamoto, Akira Shimatsu, Takeshi Usui, Rika Yamashita, Eiken Kodama, Hiroyoshi Suzuki, Kazuro Kaise, Tetsuya Tagami
Publikováno v:
Endocrine journal. 56(9)
Recent studies indicate that succinate dehydrogenase (SDH) genes B, C, or D are, at least partly, involved in the pathogenesis of pheochromocytoma or paraganglioma. Of these three genes, the SDHD gene mutation is most closely related with paraganglio
Autor:
Thomas J. Musholt, Karl J. Lackner, Mathias Schreckenberger, Matthias M. Weber, Hartmut P. H. Neumann, Christian Fottner, B. Schamberger, T. Bartenstein, Heidi Rossmann, B. Bausch, A. Helisch
Publikováno v:
Experimental and Clinical Endocrinology & Diabetes. 114